-transparent.png){kind=logo}
Because previous reports have suggested that digitalis administration may lead to increased mortality after hospital discharge for acute myocardial infarction, the independent importance of digitalis therapy in long-term prognosis after acute myocardial infarction was investigated by analyzing 1,599 patients after definite myocardial infarction. After hospital discharge, mortality rate for the entire group at 4 months was 7.7% and after 1 year 14.2%. At discharge, 36.6% of the patients were taking digitalis. Compared with those not taking digitalis, those taking digitalis had more historical risk factors and a higher incidence of important clinical prognostic variables during the hospitalization. Their cardiac mortality rate after 4 months and 1 year (12.5 and 22.4%, respectively) was significantly higher than that of patients not taking digitalis (5.0 and 9.6%, respectively). Mortality was higher for patients taking digitalis whether or not they had congestive heart failure during hospitalization. However, in a multivariate Cox analysis for 1 year outcome, neither digitalis nor any other medication variable displaced the important clinical variables of age, congestive heart failure during the hospitalization, previous myocardial infarction, maximal heart rate during the hospitalization and previous angina. Quinidine and digitalis at discharge were selected sixth and seventh (not significant) by the analysis. It is concluded that digitalis therapy at discharge after myocardial infarction was not an independent predictor of late mortality in these patients.
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
January 1975,
Heart & lung : the journal of critical care,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
July 2005,
The American journal of cardiology,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
June 2002,
European heart journal,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
March 1984,
British medical journal (Clinical research ed.),
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
January 2003,
American heart journal,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
January 1984,
British medical journal (Clinical research ed.),
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
July 2010,
European heart journal,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
January 1974,
Cardiology,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
July 1951,
Journal of the American Medical Association,
E B Madsen, and
E Gilpin, and
H Henning, and
S Ahnve, and
M LeWinter, and
J Mazur, and
R Shabetai, and
D Collins, and
J Ross
January 1973,
JAMA,
